Mr Hayes sounded pretty darn confident and convincing that they will not do this again. He obviously has VERY high expectations for this company as we all should. If what they have been developing turns into fruition and they are the leader of this new wave of biomems tech, then an RS is nowhere in the cards.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.